EZH2 and cancer: A specific EZH2 inhibitor, Tazemetostat or EPZ-6438 (35-fold stronger inhibition of EZH2 than EZH1, and ~100 fold stronger than other methyltransferases) is an FDA-approved drug used in cancer therapy15.